Harrow Health to Announce Third Quarter 2019 Financial Results on November 13, 2019
24. Oktober 2019 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Wednesday, November 13, 2019, it will release third quarter...
Solas BioVentures Co-Founder David Adair, M.D. Joins Mayfield Pharmaceuticals Board of Directors
23. Oktober 2019 07:30 ET
|
Harrow Health, Inc.
BOSTON, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Mayfield Pharmaceuticals, the women’s health-focused subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced David Adair, M.D. will join the...
Mayfield Pharmaceuticals to Present at the SVB Leerink New Treatments Focused on Women’s Health Conference on October 10, 2019
08. Oktober 2019 07:35 ET
|
Harrow Health, Inc.
BOSTON, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Mayfield Pharmaceuticals, the women’s health-focused subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its Chief Executive Officer, Melissa...
ImprimisRx to Focus on Investments in Quality at the 2019 American Academy of Ophthalmology Meeting
08. Oktober 2019 07:30 ET
|
Harrow Health, Inc.
SAN DIEGO, Oct. 08, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow...
Harrow Health to Attend Lake Street’s 3rd Annual Best Ideas Growth Conference September 12, 2019
27. August 2019 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending Lake Street’s 3rd Annual BIG Conference September 12, 2019. Mark L. Baum,...
Harrow Health Announces Second Quarter 2019 Results
14. August 2019 16:01 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the second quarter 2019. Second Quarter 2019 and Other Recent Notable Highlights: ...
Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics
02. August 2019 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that its newly formed subsidiary, Stowe Pharmaceuticals, Inc., has entered into an agreement...
Harrow Health Announces Launch of Mayfield Pharmaceuticals
31. Juli 2019 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., July 31, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), today announced it has filed a Form 8-K with the Securities and Exchange Commission containing a corporate...
Harrow Health to Announce Second Quarter 2019 Financial Results on August 14, 2019
25. Juli 2019 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., July 25, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced it will release second quarter 2019 financial results after the close of trading on Wednesday,...
Harrow Health Adds Two Senior Executives to its Nashville Team
25. Juni 2019 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., June 25, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it has promoted Dennis Saadeh, PharmD as its Chief of Formulation Strategy and has hired...